700 related articles for article (PubMed ID: 27686492)
41. The cancer glycome: carbohydrates as mediators of metastasis.
Glavey SV; Huynh D; Reagan MR; Manier S; Moschetta M; Kawano Y; Roccaro AM; Ghobrial IM; Joshi L; O'Dwyer ME
Blood Rev; 2015 Jul; 29(4):269-79. PubMed ID: 25636501
[TBL] [Abstract][Full Text] [Related]
42. Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives.
Chia J; Goh G; Bard F
Biochim Biophys Acta; 2016 Aug; 1860(8):1623-39. PubMed ID: 26968459
[TBL] [Abstract][Full Text] [Related]
43. Cytokines in the Immune Microenvironment Change the Glycosylation of IgG by Regulating Intracellular Glycosyltransferases.
Cao Y; Song Z; Guo Z; Zhao X; Gong Y; Zhao K; Qu C; Huang Y; Li Y; Gao Y; Zhang J; Guo X
Front Immunol; 2021; 12():724379. PubMed ID: 35140700
[TBL] [Abstract][Full Text] [Related]
44. [Modification of glycoconjugates during the carcinogenesis: the case of mammary carcinomas].
Guillot J; Guerry M; Konska G; Caldefie-Chezet F; De Latour M; Penault-Llorca F
Bull Cancer; 2004 Feb; 91(2):141-58. PubMed ID: 15047454
[TBL] [Abstract][Full Text] [Related]
45. A glycomics approach to the discovery of potential cancer biomarkers.
An HJ; Lebrilla CB
Methods Mol Biol; 2010; 600():199-213. PubMed ID: 19882130
[TBL] [Abstract][Full Text] [Related]
46. Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine.
Guo Y; Jia W; Yang J; Zhan X
Front Endocrinol (Lausanne); 2022; 13():970489. PubMed ID: 36072925
[TBL] [Abstract][Full Text] [Related]
47. Glycosylation Changes Triggered by the Differentiation of Monocytic THP-1 Cell Line into Macrophages.
Delannoy CP; Rombouts Y; Groux-Degroote S; Holst S; Coddeville B; Harduin-Lepers A; Wuhrer M; Elass-Rochard E; Guérardel Y
J Proteome Res; 2017 Jan; 16(1):156-169. PubMed ID: 27351377
[TBL] [Abstract][Full Text] [Related]
48. Functional roles of N-glycans in cell signaling and cell adhesion in cancer.
Zhao YY; Takahashi M; Gu JG; Miyoshi E; Matsumoto A; Kitazume S; Taniguchi N
Cancer Sci; 2008 Jul; 99(7):1304-10. PubMed ID: 18492092
[TBL] [Abstract][Full Text] [Related]
49. Importance of altered glycoprotein-bound N- and O-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells.
Lange T; Samatov TR; Tonevitsky AG; Schumacher U
Carbohydr Res; 2014 May; 389():39-45. PubMed ID: 24491280
[TBL] [Abstract][Full Text] [Related]
50. O-glycan inhibitors generate aryl-glycans, induce apoptosis and lead to growth inhibition in colorectal cancer cell lines.
Patsos G; Hebbe-Viton V; Robbe-Masselot C; Masselot D; San Martin R; Greenwood R; Paraskeva C; Klein A; Graessmann M; Michalski JC; Gallagher T; Corfield A
Glycobiology; 2009 Apr; 19(4):382-98. PubMed ID: 19122213
[TBL] [Abstract][Full Text] [Related]
51. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients.
Saeland E; Belo AI; Mongera S; van Die I; Meijer GA; van Kooyk Y
Int J Cancer; 2012 Jul; 131(1):117-28. PubMed ID: 21823122
[TBL] [Abstract][Full Text] [Related]
52. Rapid assays for lectin toxicity and binding changes that reflect altered glycosylation in mammalian cells.
Stanley P; Sundaram S
Curr Protoc Chem Biol; 2014 Jun; 6(2):117-133. PubMed ID: 24903886
[TBL] [Abstract][Full Text] [Related]
53. Advances in cell surface glycoengineering reveal biological function.
Nischan N; Kohler JJ
Glycobiology; 2016 Aug; 26(8):789-96. PubMed ID: 27066802
[TBL] [Abstract][Full Text] [Related]
54. Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis.
Shu L; Lin S; Zhou S; Yuan T
Platelets; 2024 Dec; 35(1):2315037. PubMed ID: 38372252
[TBL] [Abstract][Full Text] [Related]
55. Cystic fibrosis and bacterial colonization define the sputum N-glycosylation phenotype.
Venkatakrishnan V; Thaysen-Andersen M; Chen SC; Nevalainen H; Packer NH
Glycobiology; 2015 Jan; 25(1):88-100. PubMed ID: 25190359
[TBL] [Abstract][Full Text] [Related]
56. Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy.
Yang G; Tan Z; Lu W; Guo J; Yu H; Yu J; Sun C; Qi X; Li Z; Guan F
J Proteome Res; 2015 Feb; 14(2):639-53. PubMed ID: 25536294
[TBL] [Abstract][Full Text] [Related]
57. A Systematic Review on the Implications of O-linked Glycan Branching and Truncating Enzymes on Cancer Progression and Metastasis.
Gupta R; Leon F; Rauth S; Batra SK; Ponnusamy MP
Cells; 2020 Feb; 9(2):. PubMed ID: 32075174
[TBL] [Abstract][Full Text] [Related]
58. The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans.
Chandrasekaran EV; Xue J; Neelamegham S; Matta KL
Carbohydr Res; 2006 Jun; 341(8):983-94. PubMed ID: 16545347
[TBL] [Abstract][Full Text] [Related]
59. Glycosylation in Renal Cell Carcinoma: Mechanisms and Clinical Implications.
Zhu X; Al-Danakh A; Zhang L; Sun X; Jian Y; Wu H; Feng D; Wang S; Yang D
Cells; 2022 Aug; 11(16):. PubMed ID: 36010674
[TBL] [Abstract][Full Text] [Related]
60. Glycosylation Changes in Brain Cancer.
Veillon L; Fakih C; Abou-El-Hassan H; Kobeissy F; Mechref Y
ACS Chem Neurosci; 2018 Jan; 9(1):51-72. PubMed ID: 28982002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
